Related references
Note: Only part of the references are listed.Mechanism of CFTR correction by type I folding correctors
Karol Fiedorczuk et al.
CELL (2022)
Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial
Sivagurunathan Sutharsan et al.
LANCET RESPIRATORY MEDICINE (2022)
Novel Correctors and Potentiators Enhance Translational Readthrough in CFTR Nonsense Mutations
Venkateshwar Mutyam et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)
Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes
Peter J. Barry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Biological Characterization of F508delCFTR Protein Processing by the CFTR Corrector ABBV-2222/GLPG2222
Ashvani K. Singh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Positional effects of premature termination codons on the biochemical and biophysical properties of CFTR
Jiunn-Tyng Yeh et al.
JOURNAL OF PHYSIOLOGY-LONDON (2020)
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Miqueias Lopes-Pacheco
FRONTIERS IN PHARMACOLOGY (2020)
Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination
Guido Veit et al.
JCI INSIGHT (2020)
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
P. G. Middleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis
Jiunn-Tyng Yeh et al.
JOURNAL OF PHYSIOLOGY-LONDON (2019)
Structural mechanisms of CFTR function and dysfunction
Tzyh-Chang Hwang et al.
JOURNAL OF GENERAL PHYSIOLOGY (2018)
A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies
Daniel R. McHugh et al.
PLOS ONE (2018)
Comprehensive mapping of cystic fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding site
Steven V. Molinski et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2018)
Lost in Translation: Ribosome-Associated mRNA and Protein Quality Controls
Andrey L. Karamyshev et al.
FRONTIERS IN GENETICS (2018)
Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator ( CFTR) Translation Product*
Peter M. Haggie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
Jennifer L. Taylor-Cousar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Deep interactome profiling of membrane proteins by co-interacting protein identification technology
Sandra Pankow et al.
NATURE PROTOCOLS (2016)
Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression
Bijoyita Roy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Progress in therapies for cystic fibrosis
Kris De Boeck et al.
LANCET RESPIRATORY MEDICINE (2016)
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
Abdul Rehman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Modulation of CFTR gating by permeant ions
Han-I Yeh et al.
JOURNAL OF GENERAL PHYSIOLOGY (2015)
Understanding how cystic fibrosis mutations disrupt CFTR function: From single molecules to animal models
Yiting Wang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Mechanism-based corrector combination restores ΔF508-CFTR folding and function
Tsukasa Okiyoneda et al.
NATURE CHEMICAL BIOLOGY (2013)
A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect
Michael P. Boyle et al.
LANCET RESPIRATORY MEDICINE (2013)
Western Blot: Technique, Theory, and Trouble Shooting
Tahrin Mahmood et al.
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2012)
Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases
Kim M. Keeling et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2011)
Targeted Quantitation of Overexpressed and Endogenous Cystic Fibrosis Transmembrane Conductance Regulator Using Multiple Reaction Monitoring Tandem Mass Spectrometry and Oxygen Stable Isotope Dilution
Hui Jiang et al.
ANALYTICAL CHEMISTRY (2010)
Identification of Synergistic Combinations of F508del Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
Stephen Lin et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2010)
On the mechanism of CFTR inhibition by a thiazolidinone derivative
Zoia Kopeikin et al.
JOURNAL OF GENERAL PHYSIOLOGY (2010)
State-dependent modulation of CFTR gating by pyrophosphate
Ming-Feng Tsai et al.
JOURNAL OF GENERAL PHYSIOLOGY (2009)
Aminoglycoside antibiotics: old drugs and new therapeutic approaches
T. Hermann
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Share Paper
